Pedicetamol

Quick links to important sections

Pedicetamol

Medically reviewed

Marina Burgos

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Pedicetamol

Property Description
Active Ingredient Paracetamol (Acetaminophen)
Form Oral Solution/Drops, often concentrated
Pharmacological Class Anilide Analgesic and Antipyretic
Common Use Symptomatic relief of pain and fever
Origin Synthetic Compound

What is Pedicetamol and What Kind of Medicine Is It?

Pedicetamol is a trade name for a liquid medication focused on pediatric use, containing the active ingredient, paracetamol (acetaminophen). It is classified as an analgesic (pain reliever) and antipyretic (fever reducer).

This specific medication is supplied as an oral solution or drops, which is designed for precise and minimal-volume administration to infants and young children. Paracetamol is a synthetic compound belonging to the Anilide class of drugs, and its use is supported by established pharmacological data.


What is Pedicetamol Composed Of?

The therapeutic effect is entirely provided by the presence of the active ingredient, paracetamol. The formulation is typically designed as a highly concentrated oral solution to ensure delivery of an effective dose in small amounts.

In addition to the active drug, the solution contains excipients (non-active components), such as sweeteners and flavorings. These ingredients are necessary to create a stable, palatable medicine that is easy for a child to swallow, which is critical for compliance during home treatment.


What is the Main Therapeutic Purpose of Pedicetamol?

The general therapeutic purpose of Pedicetamol is the symptomatic management of mild to moderate pain and fever in infants and young children. It is intended for caregivers needing to manage common, transient symptoms like a high temperature or general body discomfort.

Its role is globally recognized, positioning it as a fundamental tool in the symptomatic management of pediatric illnesses. It provides comfort by reducing these physical symptoms without addressing the underlying cause of the condition itself.

Regulatory References

  1. U.S. National Library of Medicine (NIH)

What side effects are possible with Pedicetamol?

Possible side effects and safety information

The safety profile for this medicine is established by government regulatory authorities and primarily focuses on the risk of serious adverse reactions, particularly those related to dose and specific patient conditions.

Serious and Clinically Significant Risks

Hepatic (Liver) Injury: The most serious safety concern is the risk of acute liver failure, which can be severe and potentially fatal, often requiring liver transplantation. This risk is critically associated with administration of doses that exceed the maximum recommended daily limit.

Serious Skin Reactions: Rare but potentially fatal severe cutaneous adverse reactions (SCARs), including Stevens-Johnson syndrome (SJS) and Toxic Epidermal Necrolysis (TEN), have been documented. Hypersensitivity reactions, such as anaphylactic shock and hives (urticaria), have also been reported.

Adverse Reactions by Frequency

Regulatory documents classify side effects based on how often they occur in the patient population:

Frequency Classification Reported Effects (Examples)
Rare (1 to 10 in 10,000) General malaise, hypotension, increased levels of liver enzymes (transaminases).
Very Rare (Fewer than 1 in 10,000) Blood disorders (e.g., thrombocytopenia, leukopenia, neutropenia), hepatotoxicity, and anaphylactic shock.

Safety-Related Restrictions

This medicine is officially contraindicated in patients with known hypersensitivity to the active ingredient or with pre-existing severe hepatic impairment or active liver disease. Caution is specified for use in patient groups with conditions such as renal failure, chronic alcoholism, chronic malnutrition, dehydration, or glucose-6-phosphate dehydrogenase (G6PD) deficiency. Regulatory guidance emphasizes limiting use to the shortest duration necessary to mitigate risks.

Overdose and Emergency Response

Overdose and When to Seek Help: Official Regulatory Information

The most critical concern following an overdose of Pedicetamol (Paracetamol/Acetaminophen) is the risk of severe, delayed hepatic necrosis (liver damage). This condition may initially present with no symptoms or only minor, non-specific signs such as nausea, vomiting, pallor, and abdominal pain.

Immediate medical advice must be sought if an overdose is suspected, even if the individual appears well, due to the potential for delayed, life-threatening complications. Regulatory bodies mandate that patients should be referred to hospital urgently for immediate medical attention.

Overdose can progress to severe systemic outcomes, including hepatic failure, cerebral oedema, haemorrhage, and potentially death. Delayed manifestations of toxicity, such as jaundice and abnormal lab values (elevated hepatic enzymes), typically become apparent 12 to 48 hours after ingestion.

Antidote and Treatment: The specific antidote, N-acetylcysteine (NAC), is required for treatment and provides maximal protective effect when administered within 8 hours of ingestion. Urgent hospital monitoring is necessary to measure plasma paracetamol concentration and determine the course of treatment. The risk of severe toxicity is noted to be greater in vulnerable patients who are glutathione-depleted (e.g., chronic alcohol users or those with malnutrition).

Therapeutic Uses of Pedicetamol

What Pedicetamol Treats: Main Uses and Benefits

The medication is commonly used to help provide symptomatic relief in infants and children across two primary therapeutic domains, focusing on managing symptoms that interfere with daily functioning during acute, temporary episodes of illness. It is considered relevant for easing symptoms that interfere with routine activities in the pediatric population.

It is applied in clinical settings that involve acute or unstable symptom patterns, such as those related to fever and mild to moderate pain. Specific indications for this supportive assistance include general body aches, headache, earache, sore throat, and discomfort from teething.

This symptomatic relief helps address symptom clusters that may become disruptive, contributing to improved comfort during periods of heightened symptoms.

“The focus of use is to help ease the overall symptom load and support the child’s general well-being during symptomatic phases.”

Symptom Domains and Benefits

This domain addresses the application of the medicine in conditions characterized by periods of heightened symptoms, including the discomfort associated with colds and flu or post-vaccination temperature spikes. It assists with maintaining functional stability and provides supportive relief when symptoms interfere with routine activities.

Quick Fact: Relief for Pain and Fever
Symptom Category: Symptoms related to physical discomfort and systemic imbalance.
Common Use Context: Applied during phases of increased distress or discomfort associated with common, self-limiting childhood illnesses.
Core Benefit: Contributes to easing the overall symptom load, helping the child cope more steadily.

Eligibility and Restrictions for Use

Eligibility Map: Who can and cannot use Pedicetamol

The eligibility for Pedicetamol (paracetamol oral solution) is strictly defined by the regulatory documentation for its active ingredient. This section outlines the official population rules for use.


Populations with Restricted or Conditional Eligibility

Classification Population Restriction
Absolute Contraindication Patients with a known hypersensitivity to paracetamol or excipients, or those with severe active liver disease (e.g., severe hepatocellular insufficiency) [Source 1.2, 3.1].
Use with Caution Individuals with severe renal impairment (Creatinine Clearance le 30 mL/min) or moderate hepatic impairment require caution and potential interval adjustments [Source 3.1].
Conditional Use Patients with risk factors for glutathione depletion (e.g., severe malnutrition, chronic alcoholism, or sepsis) are at greater risk of toxicity and require monitoring [Source 3.2].

Age and Physiological State Rules

Age-Related Eligibility: The oral solution is primarily indicated for infants and children. Eligibility starts from birth (or ge 2 months / ge 4 kg in some labeling), but the dose must be based strictly on the child's body weight [Source 1.2, 2.3]. The active ingredient is generally allowed for adults and the elderly.

Pregnancy and Lactation Status: Use during pregnancy is permitted only when clinically necessary, at the lowest effective dose, for the shortest possible duration [Source 4.4]. Use during breastfeeding is generally not contraindicated [Source 4.1].

These official regulatory domains dictate who is eligible, who is excluded due to absolute contraindications, and for whom the medicine may only be used under conditional constraints.

What should I know about interactions with other medicines?

Pedicetamol, which contains paracetamol (acetaminophen), may interact with several medicinal products and substance categories, primarily affecting paracetamol's absorption, metabolism, or the effect of the interacting medicine.

Interactions that Affect Paracetamol

  • Enzyme Inducers: Medicines that induce hepatic enzymes, such as barbiturates, phenytoin, or rifampicin, can increase the formation of a toxic paracetamol metabolite. This raises the risk of liver damage, especially in cases of overdose or chronic alcohol use.
  • Absorption Rate Modifiers: Drugs like metoclopramide and domperidone increase the absorption of paracetamol, while cholestyramine can decrease it if administered within one hour of paracetamol.
  • Other Pain Relievers: Simultaneous use with any other medicine containing paracetamol must be avoided to prevent accidental overdose.

Interactions Affecting Other Medicines

  • Oral Anticoagulants: Chronic daily use of high paracetamol doses (mathbf2 g/day or more for more than two days) may enhance the effect of warfarin or acenocoumarol, increasing the risk of bleeding. Close monitoring is essential.
  • Flucloxacillin: Concomitant administration has been associated with the risk of pyroglutamic acidosis (a form of high anion gap metabolic acidosis), particularly in patients with risk factors like severe kidney problems, sepsis, or malnutrition. Caution and close observation are required.
  • Lamotrigine: Paracetamol may decrease the plasma levels of this anticonvulsant, potentially reducing its effectiveness.

Mechanism of Action

Pedicetamol's active ingredient, Paracetamol (Acetaminophen), exerts its action primarily within the Central Nervous System (CNS) by modulating specific biochemical signaling pathways.

Inhibition of Central Cyclooxygenase Activity

This mechanism involves the inhibition of cyclooxygenase (COX) enzyme activity, particularly the COX-2 enzyme or its variants, predominantly within the brain and spinal cord. Paracetamol blocks the synthesis of prostaglandins (PGs) like PGE2, which serve as crucial signaling molecules for afferent neural responses and thermoregulatory centers. This action results in a reduction of PGE2-mediated signaling within the targeted neural and non-neural pathways.

Influence on Endogenous Signaling Systems

The drug's pharmacodynamic profile also includes indirect modulation of pathways through its active metabolite, AM404. This metabolite interacts with and affects the activity of the endocannabinoid and serotonergic descending pain inhibitory pathways in the CNS. These interactions adjust the activity within targeted pathways by initiating or suppressing specific signaling sequences that influence heightened physiological activity through molecular modification.

Dosage and Administration Information

How to Use Pedicetamol (Paracetamol 100 mg/ mL Oral Solution)

The usage instructions for Pedicetamol are strictly defined for the product, emphasizing accurate, weight-based dosing and adherence to time intervals to ensure correct administration. The drug is administered via the Oral route.

Dosing and Administration Rules

Guideline Official Instruction Basis
Dosing Calculation Dosage is strictly based on the patient's body weight in kilograms (kg), not age. The standard single dose is 10–15 mg/ kg.
Frequency Doses may be repeated as needed, but a minimum interval of 4 hours must be maintained between administrations.
Maximum Dose The total quantity of paracetamol must not exceed 60 mg/ kg over any 24-hour period for children.
Measurement The dose must be accurately measured using the specific dropper or oral syringe provided with the package.

Procedural Steps and Constraints

  1. Determine Weight: Establish the child's current body weight to calculate the correct dose volume.
  2. Preparation: The bottle of oral solution must be shaken well for at least 10 seconds before measurement.
  3. Administration: Draw the calculated volume using the provided measuring device and administer the dose directly or diluted in liquid.
  4. Timing: Record the time of administration and ensure the minimum 4-hour interval is observed before administering a subsequent dose.

For adults and adolescents weighing over 50 kg, the single-dose is typically 500–1000 mg, with the maximum daily dose generally not exceeding 3000 mg. Patients with renal or hepatic impairment have specific, reduced dosing schedules or prolonged dose intervals mandated by official labeling.

Recent Clinical Evidence

Research Evidence / Overview of Studies

Research Focus and Primary Findings

Pedicetamol is an oral solution containing paracetamol (acetaminophen), which is widely studied for its ability to address fever (antipyretic) and mild to moderate pain (analgesic) in pediatric populations. Research has explored whether paracetamol is associated with changes in both fever and pain scores in children from infancy onward.

  • Antipyretic Effect: Clinical trials and systematic reviews consistently show that paracetamol is associated with a reduction in body temperature in febrile children. However, some evidence suggests that the benefits of its use for fever may be unclear in specific contexts, such as certain viral origins.
  • Analgesic Effect: Studies have evaluated the results of paracetamol for various types of pain, including pain associated with acute otitis media (AOM) and post-operative pain. Research indicates paracetamol is often utilized as a first-line agent, sometimes in combination with other analgesics, to manage pain.

Safety Profile and Limitations

Paracetamol is one of the most widely used pediatric medications, and at therapeutic doses, it is generally considered safe for short-term use in otherwise healthy children. However, a small number of studies have highlighted areas of caution and the need for ongoing research:

  • Liver Function: Evidence is available to conclude that paracetamol does not induce acute liver damage in babies or children when used as directed. However, transient elevations of liver enzyme levels have been documented in some research settings.
  • Neurodevelopmental Studies: Some systematic reviews have concluded that while the drug has been proven safe for acute side effects, its safety concerning long-term neurodevelopmental outcomes has not been comprehensively monitored in human clinical trials, leading to ongoing debate and caution among researchers.

Research continues to investigate the optimal therapeutic role and safety profile of paracetamol across varied pediatric groups.

Key Studies & References

  1. Therapeutic acetaminophen is not associated with liver injury in children: a systematic review - PubMed

Frequently Asked Questions (FAQ)

Common questions about Pedicetamol (FAQ)


Q: What is the main difference between Pedicetamol and generic paracetamol syrup?

The active ingredient in both Pedicetamol and generic paracetamol syrup is the same: paracetamol. This ingredient works to relieve pain and fever. The primary difference is often found in the inactive ingredients (excipients), such as preservatives, sweeteners, flavorings, and colors, which are unique to each formulation or brand. These ingredients are fully disclosed on the official product labeling.


Q: Why is Pedicetamol often prescribed for children instead of tablets?

Official dosing guidelines emphasize the use of liquid formulations for infants and young children primarily to support accuracy. Liquid drops allow caregivers to measure the precise, weight-based dose required for the child using a specific measuring device, which is a necessary control measure to help prevent administration errors and support correct dosing.


Q: Is Pedicetamol available in a flavourless or unflavored version?

Pediatric oral solutions commonly contain flavorings to make the medicine easier for a child to take. The full list of excipients, including any flavorings, is found in the official product label. If an unflavored version exists, its regulatory label should not list flavorings among the inactive ingredients.


Q: Does Pedicetamol contain sugar or artificial sweeteners?

The specific composition of the medicine, including all inactive ingredients, is detailed in the official product information. This section lists whether the solution contains traditional sugars, artificial sweeteners (such as aspartame), or sugar substitutes to ensure the medicine is palatable for children.


Q: How quickly does Pedicetamol start working for fever?

According to the pharmacokinetics (how the body handles the drug), the active ingredient paracetamol is usually absorbed and reaches its highest concentration in the bloodstream within 0.5 to 2 hours after being taken. The peak effect for reducing fever is generally observed within 1 to 3 hours after administration.


Q: What is the typical duration of pain relief provided by Pedicetamol?

Studies and official information indicate that the analgesic (pain-relieving) effect of paracetamol typically lasts for 3 to 4 hours. This duration is consistent with the minimum time interval between doses often cited in official product instructions.


Q: Can Pedicetamol be used to treat teething pain in babies?

Official labeling indicates that paracetamol is for the symptomatic relief of minor aches and pains. While specific conditions like teething pain are not always listed, the drug's general indication covers a range of common, minor pain symptoms in children.


Q: Is Pedicetamol effective for headaches in toddlers?

Official regulatory documents indicate that the active ingredient, paracetamol, is used for the symptomatic relief of headache in children. It works by addressing the mild to moderate pain associated with common headaches.


Q: What kind of side effects are common with Pedicetamol?

Official safety data indicates that paracetamol is generally well-tolerated at therapeutic doses and rarely causes common side effects. The official safety profile primarily focuses on serious risks, which are classified as Rare or Very Rare events. Users should always observe the child for any unexpected reactions.


Q: Is it normal if a child feels a little sick after taking Pedicetamol?

While nausea or vomiting are not typically reported as common side effects at therapeutic doses, they are known symptoms associated with paracetamol, especially in cases of over-administration. If gastrointestinal upset occurs, observation of the child may be necessary, and persistent or worsening symptoms should be brought to the attention of a healthcare professional.


Q: Are there any common supplements or vitamins that interact with Pedicetamol?

Regulatory warnings focus on drug interactions and conditions that can increase the risk of toxicity, such as those leading to the depletion of glutathione. This compound is vital for safely metabolizing paracetamol. Conditions like severe malnutrition (which can involve vitamin deficiencies) are noted as risk factors in official documents.


Q: Is Pedicetamol safe for children with kidney or liver issues?

The official eligibility rules state that the medicine is contraindicated in patients with severe active liver disease. This means the medicine is not recommended for use in this group. Caution and a possible dose interval adjustment are also required for individuals with severe renal (kidney) impairment or moderate hepatic (liver) impairment.


Q: At what age is Pedicetamol typically not recommended anymore?

Paracetamol is generally approved for use across all age groups, from infants (dose based on weight) to adults and the elderly. Children typically transition from pediatric liquid doses to standard adult oral doses (e.g., 500 mg tablets) around 10 to 12 years of age or 50 kg body weight, but the drug itself remains appropriate for use.


Q: What is the main purpose of the included dropper or syringe with Pedicetamol?

The included dosing device is provided to support accurate administration of the medicine. Its purpose is to help ensure the dose is measured precisely according to the child's weight, which is an important step mandated by regulatory guidelines to prevent administration errors.


Q: Can Pedicetamol be mixed with food or drinks, and does it affect its effectiveness?

Administration guidelines for paracetamol generally allow it to be taken with or without food. Although some instructions permit dilution in liquid, taking the medicine with a heavy, high-fat meal may slow down the absorption of the medicine, which could result in a minor delay in the onset of the effect.


Q: What are the signs that Pedicetamol is not working for a child's pain or fever?

Official regulatory information advises consulting a healthcare professional if adequate relief is not achieved. Consultation is recommended if the fever worsens or persists beyond a specified period (e.g., 3 days), or if the pain lasts beyond a specified period (e.g., 5 days), or if new symptoms occur.


Q: What happens if a child spits out some of the Pedicetamol right after taking it?

General guidance often addresses scenarios where a dose may be given again if expelled shortly after administration (e.g., less than 30 minutes). If a longer time has passed, the instructions typically recommend not redosing and waiting until the next scheduled time. Dose-specific instructions should always be obtained from the product label or a healthcare professional.


Q: What concentration (e.g., mg/mL) is Pedicetamol usually sold in?

Pedicetamol, being a highly concentrated oral solution, is typically sold in concentrations that require small volumes for accurate dosing. Examples of common pediatric paracetamol concentrations include 100 mg/ mL drops, or in other markets, concentrations like 24 mg/ mL or 32 mg/ mL syrups.


Q: How does Pedicetamol help with pain versus reducing fever?

The drug functions through a shared biological mechanism: it reduces the production of signaling chemicals called prostaglandins in the Central Nervous System. By modulating these signals, it simultaneously helps lower the body's thermoregulatory set point (reducing fever) and minimizes the body's perception of pain.


Q: What are the typical ingredients besides the active medication in Pedicetamol solution?

In addition to the active ingredient paracetamol, the solution contains excipients listed in the official label. These typically include: sweeteners (e.g., sorbitol), flavorings, preservatives (e.g., benzoic acid), buffers (e.g., citric acid), and potentially coloring agents to ensure the product is stable and palatable.


Q: Does Pedicetamol contain any common allergens like dairy or nuts?

Regulatory documents require a full listing of all inactive ingredients (excipients). If an excipient is derived from a known common allergen, such as specific starches or other compounds, official regulatory guidance specifies that the presence of such allergens in the excipients must be disclosed on the product labeling.


Q: What are the safety warnings about using Pedicetamol past the 'discard after opening' date?

The 'discard after opening' date is established by the manufacturer and regulators based on product stability and safety testing. Using the medicine after this period may compromise its effectiveness or increase the risk of microbial contamination, potentially making it unsuitable for use.

How should Pedicetamol be stored and disposed of?

Pedicetamol, like all medicines containing paracetamol, must be stored correctly to maintain its effectiveness and ensure safety.

Storage Guidelines

Condition Recommendation
Temperature Store at room temperature, typically between 59 F and 77 F (15 C and 25 C).
Environment Keep the original container in a cool, dry place, away from direct sunlight, heat, and moisture (e.g., avoid the bathroom medicine cabinet).
Safety Always keep the medication securely closed and out of the sight and reach of children and pets.

Disposal

Do not dispose of this medicine in household wastewater or trash, as this can affect the environment. The preferred method for disposing of expired or unused Pedicetamol is through a medicine take-back program available in your community, such as a pharmacy drop-off or a community collection event. If a take-back program is unavailable, consult with your pharmacist or local waste management for guidance on safe household disposal methods to protect public health and the environment.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Pedicetamol found in:

A-Z Index: